NCT04604249

Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World

Prevalence of COVID-19 and Risk Factors Associated With Seroconversion in La Rinconada, the Highest City of the World - 5,100 m

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: Centre d'Expertise sur l'Altitude EXALT · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Since the beginning of 2020, SARS-CoV-2 outbreak spread over the world, conducting in a pandemic state declared by the world health organization in March 2020. Conflicting data have been yet published regarding to the incidence rate of COVID-19 infection in altitude. Mainly based on analysis from national Peru database, some authors argued that COVID-19 disease, as well as case fatality rate was less frequent in altitude. However, epidemiological data are lacking regarding to the prevalence of COVID-19 in altitude, and more specially in high altitude. Aim of this cross-sectional study is to assess the prevalence of seroconversion for the SARS-CoV-2 in the population of La Rinconada, a mining town at 5,100 m, the highest city in the world.

Conditions

• Covid19
• High Altitude

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	SARS-CoV-2 rapid diagnostic test (COVID-PRESTO® IgM/IgG, AAZ, Boulogne-Billancourt, France)	Presence of specific SARS-CoV-2 antibodies (IgM or IgG).

Timeline

• Start date: 2020-10-26
• Primary completion: 2021-11-30
• Completion: 2021-12-31
• First posted: 2020-10-27
• Last updated: 2021-02-04

Locations

1 site across 1 country: Peru